Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Advanced clinical trials unit sets benchmark for innovative R&D in the UAE

Article-Advanced clinical trials unit sets benchmark for innovative R&D in the UAE

Image via Canva Pro clinical trials
The unit is part of Sheikh Shakbout Medical City’s 10-year plan to create opportunities for local and regional researchers.

Abu Dhabi is home to one of the most advanced clinical trial units, designed to perform world-class research with the aim of translating scientific discoveries into innovative treatments to solve complex and prevalent conditions in the region.  

The unit belonging to Sheikh Shakbout Medical City (SSMC) is equipped with cutting-edge technology and led by a dedicated team of researchers conducting pioneering research, including investigational and observational studies, and complex trials in areas with unmet medical needs. These research areas include neurology, rheumatology, haematology, oncology, cardiology, ophthalmology, gastroenterology and paediatrics. 

In partnership with the Department of Health – Abu Dhabi (DoH), Khalifa University and other academic institutions, the trial unit has helped set a new benchmark for innovative research and development in the UAE.  

The mission is to transform the region into a life sciences hub, and respond to pressing present and future health challenges, while also contributing to creating a more sustainable and self-reliant healthcare system, said Dr. Sharukh Hashmi, Consultant, Chair of Hematology & Oncology Division and Acting Director of Research at Sheikh Shakhbout Medical City (SSMC). 

RelatedDecentralised clinical trials are amplifying health equity

The trials unit is part of a multi-phase approach that spans over a period of 10 years in the region. The first phase will focus on the establishment of the unit’s core infrastructure and initial operations, while the second phase has been planned to create a dedicated physical space. In its third phase, the unit will extensively investigate business development and entrepreneurship opportunities.  

Dr. Hashmi believes the establishment of this unit is a positive move for the MENA healthcare industry. “Operating in a research and academic environment, acquiring new knowledge and skills, seeking new solutions and innovation can provide better care to patients in the UAE and across the region, thus successfully delivering on their mission of placing people’s needs first,” he said.  

He further added: “In an era of ageing populations, the spread of infectious diseases, an epidemic of lifestyle diseases, the rise of misinformation, and a lack of public trust, there is an increasingly pressing need to address complex care challenges through research and innovation as a mean to safeguard and invest in our future.” 

Besides streamlining healthcare delivery and providing optimal medical solutions, the unit is expected to create more opportunities for local and regional researchers, thus encouraging the newer generation to pursue a career in medical research.  

 

Back to Management

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish